IN2015DN02782A - - Google Patents
Info
- Publication number
- IN2015DN02782A IN2015DN02782A IN2782DEN2015A IN2015DN02782A IN 2015DN02782 A IN2015DN02782 A IN 2015DN02782A IN 2782DEN2015 A IN2782DEN2015 A IN 2782DEN2015A IN 2015DN02782 A IN2015DN02782 A IN 2015DN02782A
- Authority
- IN
- India
- Prior art keywords
- composition
- cancer
- risk
- nicotine
- prevention
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G4/00—Chewing gum
- A23G4/06—Chewing gum characterised by the composition containing organic or inorganic compounds
- A23G4/068—Chewing gum characterised by the composition containing organic or inorganic compounds containing plants or parts thereof, e.g. fruits, seeds, extracts
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G4/00—Chewing gum
- A23G4/06—Chewing gum characterised by the composition containing organic or inorganic compounds
- A23G4/12—Chewing gum characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
- A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
- A24B15/10—Chemical features of tobacco products or tobacco substitutes
- A24B15/16—Chemical features of tobacco products or tobacco substitutes of tobacco substitutes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/465—Nicotine; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
- A61K31/6615—Compounds having two or more esterified phosphorus acid groups, e.g. inositol triphosphate, phytic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
- A61K9/0058—Chewing gums
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0065—Inhalators with dosage or measuring devices
- A61M15/0068—Indicating or counting the number of dispensed doses or of remaining doses
- A61M15/008—Electronic counters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0065—Inhalators with dosage or measuring devices
- A61M15/0068—Indicating or counting the number of dispensed doses or of remaining doses
- A61M15/0083—Timers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/06—Inhaling appliances shaped like cigars, cigarettes or pipes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24F—SMOKERS' REQUISITES; MATCH BOXES; SIMULATED SMOKING DEVICES
- A24F13/00—Appliances for smoking cigars or cigarettes
- A24F13/02—Cigar or cigarette holders
- A24F13/12—Cigar or cigarette holders combined with other objects, e.g. writing utensils
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0085—Inhalators using ultrasonics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2202/00—Special media to be introduced, removed or treated
- A61M2202/06—Solids
- A61M2202/064—Powder
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- Heart & Thoracic Surgery (AREA)
- Anesthesiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Nutrition Science (AREA)
- Polymers & Plastics (AREA)
- Biophysics (AREA)
- Inorganic Chemistry (AREA)
- Food Science & Technology (AREA)
- Microbiology (AREA)
- Dermatology (AREA)
- Zoology (AREA)
- Botany (AREA)
- Physiology (AREA)
- Addiction (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261703999P | 2012-09-21 | 2012-09-21 | |
US14/013,019 US20140088045A1 (en) | 2012-09-21 | 2013-08-28 | Product comprising a nicotine-containing material and an anti-cancer agent |
PCT/US2013/061206 WO2014047569A2 (en) | 2012-09-21 | 2013-09-23 | Product comprising a nicotine-containing material and an anti-cancer agent |
Publications (1)
Publication Number | Publication Date |
---|---|
IN2015DN02782A true IN2015DN02782A (ko) | 2015-09-04 |
Family
ID=50339457
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IN2782DEN2015 IN2015DN02782A (ko) | 2012-09-21 | 2013-09-23 |
Country Status (9)
Country | Link |
---|---|
US (2) | US20140088044A1 (ko) |
EP (1) | EP2916847A4 (ko) |
JP (1) | JP2015531793A (ko) |
KR (1) | KR20150084794A (ko) |
CN (1) | CN104918621A (ko) |
CA (1) | CA2885739A1 (ko) |
EA (1) | EA201590585A1 (ko) |
IN (1) | IN2015DN02782A (ko) |
WO (1) | WO2014047569A2 (ko) |
Families Citing this family (38)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9895321B2 (en) * | 2010-04-23 | 2018-02-20 | Aktiv-Dry Llc | Vaccines, methods of administering vaccines, methods and products for treating and/or delaying onset of dysplastic lesions, and wafers for oral administration |
CA2822738C (en) | 2010-12-22 | 2021-06-08 | Exonoid Medical Devices Ltd. | Method and system for drug delivery |
FR3015186A1 (fr) * | 2014-03-11 | 2015-06-26 | Antoine Piccirilli | Utilisation d'une composition renfermant du 1,3-propanediol comme e-liquide |
WO2015148649A2 (en) * | 2014-03-26 | 2015-10-01 | Basil Rigas | Systems and methods for ameliorating the effects of tobacco products |
CN105828819A (zh) * | 2014-04-08 | 2016-08-03 | 桑萨(巴巴多斯)公司 | 烟碱制剂及其制备方法 |
CA2943746C (en) | 2014-04-28 | 2023-08-15 | Philip Morris Products S.A. | Flavoured nicotine powder inhaler |
PL3136894T3 (pl) * | 2014-04-28 | 2020-02-28 | Philip Morris Products S.A. | Inhalator proszku nikotynowego |
US10508096B2 (en) | 2014-05-27 | 2019-12-17 | R.J. Reynolds Tobacco Company | Nicotine salts, co-crystals, and salt co-crystal complexes |
US9896429B2 (en) | 2014-05-27 | 2018-02-20 | R.J. Reynolds Tobacco Company | Nicotine salts, co-crystals, and salt co-crystal complexes |
CN106536501A (zh) * | 2014-05-27 | 2017-03-22 | R.J.雷诺兹烟草公司 | 烟碱盐、共晶体和盐共晶体络合物 |
GB2527597B (en) * | 2014-06-27 | 2016-11-23 | Relco Induction Dev Ltd | Electronic Vapour Inhalers |
WO2016001922A1 (en) * | 2014-06-30 | 2016-01-07 | Syqe Medical Ltd. | Methods, devices and systems for pulmonary delivery of active agents |
US11298477B2 (en) | 2014-06-30 | 2022-04-12 | Syqe Medical Ltd. | Methods, devices and systems for pulmonary delivery of active agents |
EP3160565B1 (en) | 2014-06-30 | 2021-08-18 | Syqe Medical Ltd. | Devices and systems for pulmonary delivery of active agents |
EP3160553B1 (en) | 2014-06-30 | 2021-10-20 | Syqe Medical Ltd. | Device for vaporization and inhalation of isolated substances |
BR112016030955B1 (pt) | 2014-06-30 | 2022-03-22 | Syqe Medical Ltd. | Dispositivo inalador |
EP3160552B1 (en) | 2014-06-30 | 2019-05-08 | Syqe Medical Ltd. | Drug dose cartridge for an inhaler device |
WO2016069903A1 (en) | 2014-10-29 | 2016-05-06 | Altria Client Services Llc | E-vaping cartridge |
WO2016069876A1 (en) | 2014-10-29 | 2016-05-06 | Altria Client Services Llc | Ethanol-free gel formulation cartridge for e-vaping device |
CN104544542B (zh) * | 2014-12-24 | 2017-04-26 | 广西中烟工业有限责任公司 | 一种真空冷冻干燥薄荷粒电子烟油的制备方法 |
GB2534210B (en) * | 2015-01-19 | 2017-07-19 | Ngip Res Ltd | Aerosol-generating article |
JP7189765B2 (ja) * | 2015-04-15 | 2022-12-14 | フィリップ・モーリス・プロダクツ・ソシエテ・アノニム | 吸入装置のための香味要素 |
US9585835B1 (en) * | 2015-09-16 | 2017-03-07 | Sansa Corporation (Barbados) Inc. | Inhalable nicotine formulations and methods of making and using the same |
US10149844B2 (en) | 2015-09-16 | 2018-12-11 | Philip Morris Products S.A. | Inhalable nicotine formulations, and methods of making and using thereof |
CN114656446A (zh) * | 2015-11-25 | 2022-06-24 | R.J.雷诺兹烟草公司 | 烟碱盐、共晶体和盐共晶体配合物 |
MY186270A (en) | 2015-12-24 | 2021-07-01 | Philip Morris Products Sa | Flavoured nicotine powder |
CN113273731A (zh) * | 2015-12-24 | 2021-08-20 | 菲利普莫里斯生产公司 | 尼古丁粉末递送系统 |
CA3008996A1 (en) | 2015-12-24 | 2017-06-29 | Philip Morris Products S.A. | Nicotine particle capsule |
US11806331B2 (en) | 2016-01-06 | 2023-11-07 | Syqe Medical Ltd. | Low dose therapeutic treatment |
US9867397B2 (en) | 2016-01-11 | 2018-01-16 | Patrick Beymer | Nicotine delivery system |
GB201602831D0 (en) * | 2016-02-18 | 2016-04-06 | British American Tobacco Co | Flavour delivery device |
RU2734847C2 (ru) | 2016-07-07 | 2020-10-23 | Филип Моррис Продактс С.А. | Ингаляционная система для никотина |
US20180036496A1 (en) * | 2016-08-02 | 2018-02-08 | James Riviello | Medication Delivery System |
WO2020235007A1 (ja) * | 2019-05-21 | 2020-11-26 | 日本たばこ産業株式会社 | 加熱型香味吸引器用香料含有シートおよび加熱型香味吸引器 |
WO2021126313A1 (en) * | 2019-07-15 | 2021-06-24 | The Research Foundation For The State University Of New York | Nicotine materials, methods of making same, and uses thereof |
LU101519B1 (en) * | 2019-12-02 | 2021-06-07 | Herrera Arturo Solis | (S)-3-[1-MethyIpyrrolidin-2-yl]pyridine, analogues thereof, precursors thereof, or its derivatives, for the use as a pharmaceutical in form of a solid substance and a tablet |
EP4245745A1 (en) * | 2020-11-13 | 2023-09-20 | Japan Tobacco Inc. | Tobacco extract containing cembratriendiol and production method therefor |
WO2024090890A1 (ko) * | 2022-10-27 | 2024-05-02 | 주식회사 케이티앤지 | 흡입용 저용량 니코틴 건조 분말 조성물 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050236006A1 (en) * | 2004-04-24 | 2005-10-27 | Anderson Cowan | Smoking cessation devices, methods of use and methods of conducting business therewith |
AU2008286954B2 (en) * | 2007-08-10 | 2015-01-15 | Basil Rigas | Anti-inflammatory compounds and uses thereof |
US20100124560A1 (en) * | 2008-11-14 | 2010-05-20 | Mcneil Ab | Multi portion intra-oral dosage form and use thereof |
EP2560659A4 (en) * | 2010-04-19 | 2013-05-01 | Stanford Res Inst Int | COMPOSITIONS AND METHODS FOR TREATING MULTIPLE MYELOMA |
WO2011133215A1 (en) * | 2010-04-19 | 2011-10-27 | Health Research Inc. | Method of identifying and treating a person having a predisposition to or afflicted with parkinson disease |
-
2013
- 2013-08-28 US US14/013,004 patent/US20140088044A1/en not_active Abandoned
- 2013-08-28 US US14/013,019 patent/US20140088045A1/en not_active Abandoned
- 2013-09-23 KR KR1020157010149A patent/KR20150084794A/ko not_active Application Discontinuation
- 2013-09-23 JP JP2015533249A patent/JP2015531793A/ja active Pending
- 2013-09-23 EA EA201590585A patent/EA201590585A1/ru unknown
- 2013-09-23 EP EP13882621.9A patent/EP2916847A4/en not_active Withdrawn
- 2013-09-23 CA CA2885739A patent/CA2885739A1/en not_active Abandoned
- 2013-09-23 IN IN2782DEN2015 patent/IN2015DN02782A/en unknown
- 2013-09-23 CN CN201380060815.2A patent/CN104918621A/zh active Pending
- 2013-09-23 WO PCT/US2013/061206 patent/WO2014047569A2/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
US20140088045A1 (en) | 2014-03-27 |
CN104918621A (zh) | 2015-09-16 |
EP2916847A2 (en) | 2015-09-16 |
WO2014047569A9 (en) | 2014-05-30 |
EA201590585A1 (ru) | 2016-04-29 |
CA2885739A1 (en) | 2014-03-27 |
WO2014047569A3 (en) | 2014-07-17 |
JP2015531793A (ja) | 2015-11-05 |
KR20150084794A (ko) | 2015-07-22 |
US20140088044A1 (en) | 2014-03-27 |
WO2014047569A2 (en) | 2014-03-27 |
EP2916847A4 (en) | 2016-06-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IN2015DN02782A (ko) | ||
WO2015148649A3 (en) | Systems and methods for ameliorating the effects of tobacco products | |
MY163517A (en) | Improved device and method for delivery of a medicament | |
MX2009009428A (es) | Analogos de ciclopamina heterociclicos y metodos de uso de los mismos. | |
MX2020010535A (es) | Inhibidor de ezh2 para usarse en el tratamiento de sarcoma epiteloide. | |
HK1139930A1 (en) | Cyclopamine lactam analogs and methods of use thereof | |
PH12016500575A1 (en) | Inhibitors of bruton`s tyrosine kinase | |
SG178873A1 (en) | Combination therapy with nanoparticle compositions of taxane and hedgehog inhibitors | |
MX2016007851A (es) | Compuestos peptidomimeticos y conjugados anticuerpo-farmaco de estos. | |
PH12015500940A1 (en) | Bruton`s tyrosine kinase inhibitors | |
MX2016007826A (es) | Compuestos peptidomimeticos y sus conjugados de anticuerpo-farmaco. | |
MX2013010340A (es) | Combinacion de terapias inmunomoduladoras local y sistemica para tratamiento mejorado del cancer. | |
TR201903110T4 (tr) | Bir sigara ürünü için bir filtre. | |
MX2019010601A (es) | Terapia de combinacion para tratar cancer. | |
NZ748451A (en) | Methods for treating atopic dermatitis by administering an il-4r antagonist | |
SG10201811128RA (en) | Ezh2 inhibitors for treating lymphoma | |
MY166014A (en) | Combination therapy methods for treating proliferative diseases | |
MY181602A (en) | Isochromene derivatives as phosphoinositide 3-kinases inhibitors | |
PH12015500062A1 (en) | 3-substituted estra-1,3,5(10),16-tetraene derivatives, methods for the production thereof, pharmaceutical preparations containing same, and use thereof for the production of medicaments | |
WO2012005885A3 (en) | Nutraceutical product containing anatabine and yerba maté | |
CA2806614C (en) | Combinatory cancer treatment | |
MX2011011126A (es) | Composiciones y metodos para tratar quemaduras. | |
MX2015004362A (es) | Derivados de ketamina. | |
MX363746B (es) | Oligonucleótidos antisentido de smad7 para el tratamiento de cáncer colorrectal. | |
EP3458057A4 (en) | PHARMACEUTICAL FORMULATIONS WITH CANNABIDIOL AND NICOTINE FOR THE TREATMENT OF THE ADDICTION FOR SMOKING TOBACCO |